The Safety and Tolerability of STSA-1002 Following Subcutaneous Injection in Healthy Subjects

Clinical trial NCT05702983 · COMPLETED

Trial details

NCT number: NCT05702983
Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Antineutrophil Cytoplasmic Antibody Associated Vasculitis

Start date: 2023-01-31
Primary completion: 2023-04-11
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.